18th May 2022
News
Press Releases
SwanBio Therapeutics Announces $56 Million Series B Financing to Advance Novel Gene Therapies for Neurological Conditions
New funding will support ongoing clinical development of lead candidate, SBT101 for adrenomyeloneuropathy (AMN). New funding will support ongoing clinical...